Literature DB >> 26248249

Evidences in the treatment of idiopathic normal pressure hydrocephalus.

Matheus Fernandes de Oliveira1, Rodolfo Casimiro Reis2, Evelinda Marramon Trindade3, Fernando Campos Gomes Pinto4.   

Abstract

INTRODUCTION: idiopathic normal pressure hydrocephalus (INPH) is characterized by gait apraxia, cognitive dysfunction and urinary incontinence. There are two main treatment options: ventriculoperitoneal shunt (VPS) and endoscopic third ventriculostomy (ETV). However, there are doubts about which modality is superior and what type of valve should be applied. We are summarizing the current evidence in INPH treatment.
METHODS: an electronic search of the literature was conducted on the Medline, Embase, Scielo and Lilacs databases from 1966 to the present to obtain data published about INPH treatment.
RESULTS: the treatment is based on three pillars: conservative, ETV and VPS. The conservative option has fallen into disuse after various studies showing good results after surgical intervention. ETV is an acceptable mode of treatment, but the superiority of VPS has made the latter the gold standard.
CONCLUSION: well-designed studies with a high level of appropriate evidence are still scarce, but the current gold standard for treatment of INPH is conducted using VPS.

Entities:  

Mesh:

Year:  2015        PMID: 26248249     DOI: 10.1590/1806-9282.61.03.258

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  2 in total

Review 1.  Escalate and De-Escalate Therapies for Intracranial Pressure Control in Traumatic Brain Injury.

Authors:  Denise Battaglini; Pasquale Anania; Patricia R M Rocco; Iole Brunetti; Alessandro Prior; Gianluigi Zona; Paolo Pelosi; Pietro Fiaschi
Journal:  Front Neurol       Date:  2020-11-24       Impact factor: 4.003

2.  Asymmetric hearing loss and chronic dizziness in a patient with idiopathic normal pressure hydrocephalus.

Authors:  Theodoros Varakliotis; Federico Maspes; Vittoria Di Rubbo; Sara Cisternino; Maria Lauriello; Elisa Vitti; Alberto Eibenstein
Journal:  Audiol Res       Date:  2018-06-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.